Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver

• Published in: Phytomedicine (Stuttgart) Vol. 118; p. 154937
• Main Authors: Liao, Jiabao, Cao, Yongjun, Zhao, Jie, Yu, Bolun, Wang, Yuming, Li, Wenting, Li, Hanzhou, Lv, Shuquan, Wen, Weibo, Cui, Huantian, Chen, Yao
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.09.2023
• Subjects: Gut microbiota; Histidine metabolism; Nonalcoholic steatohepatitis; Polygala japonica Houtt; Tryptophan metabolism; Gut microbiota; NAS; AST; GSH-Px; PPC; Tryptophan metabolism; Polygala japonica Houtt; ALT; SOD; MDA; NASH; MCD; TC; GVB; Nonalcoholic steatohepatitis; Histidine metabolism; TG; AOD; F/B; PJ; TCM
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2023.154937

Polygala japonica Houtt. (PJ) has been demonstrated with several biological potentials such as lipid-lowering and anti-inflammatory effects. However, the effects and mechanisms of PJ on nonalcoholic steatohepatitis (NASH) remain unclear. The aim of this study was to evaluate the effects of PJ on NASH and illustrate the mechanism based on modulating gut microbiota and host metabolism. NASH mouse model was induced using methionine and choline deficient (MCD) diet and orally treated with PJ. The therapeutic, anti-inflammatory, and anti-oxidative effects of PJ on mice with NASH were firstly assessed. Then, the gut microbiota of mice was analyzed using 16S rRNA sequencing to assess the changes. Finally, the effects of PJ on the metabolites in liver and feces were explored by untargeted metabolomics. The results indicated that PJ could improve hepatic steatosis, liver injury, inflammatory response, and oxidative stress in NASH mice. PJ treatment also affected the diversity of gut microbiota and changed the relative abundances of Faecalibaculum. Lactobacillus, Muribaculaceae, Dubosiella, Akkermansia, Lachnospiraceae_NK4A136_group, and Turicibacter in NASH mice. In addition, PJ treatment modulated 59 metabolites both in liver and feces. Metabolites involved in histidine, and tryptophan metabolism pathways were identified as the key metabolites according to the correlation analysis between differential gut microbiota and metabolites. Our study demonstrated the therapeutic, anti-inflammatory and anti-oxidative potentials of PJ on NASH. The mechanisms of PJ treatment were related to the improvement of gut microbiota dysbiosis and the regulation of histidine and tryptophan metabolism.